Evidence map›Paper›PMID 37013112›Full record

ArticleThe Lancet regional health. Europe2023

Factors associated with receipt of COVID-19 vaccination and SARS-CoV-2 seropositivity among healthcare workers in Albania (February 2021-June 2022): secondary analysis of a prospective cohort study.

Pernille Jorgensen, Alexis Schmid, Jonilda Sulo, Iria Preza, Iris Hasibra, Esther Kissling, Albana Fico, Shela Sridhar, Julia E Rubin-Smith, Majlinda Kota and 7 more

Open access · goldAbstract read
In one paragraph

Article in The Lancet regional health. Europe, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 3 countries.

Pernille JorgensenWorld Health Organization, Regional Office for Europe, Marmorvej 51, 2100, Copenhagen, Denmark.
Alexis SchmidBoston Children's Hospital Global Health Program, Boston, MA, USA.
Jonilda SuloSoutheast European Center for Surveillance and Control of Infectious Diseases, Alexander Moisiut Street N.80, 1001, Tirana, Albania.
Iria PrezaInstitute of Public Health, Alexander Moisiut Street N.80, 1001, Tirana, Albania.
Iris HasibraInstitute of Public Health, Alexander Moisiut Street N.80, 1001, Tirana, Albania.
Esther KisslingEpiconcept, 25 Rue Titon, 75011, Paris, France.
Albana FicoInstitute of Public Health, Alexander Moisiut Street N.80, 1001, Tirana, Albania.
Shela SridharBoston Children's Hospital Global Health Program, Boston, MA, USA.
Julia E Rubin-SmithBoston Children's Hospital Global Health Program, Boston, MA, USA.
Majlinda KotaInstitute of Public Health, Alexander Moisiut Street N.80, 1001, Tirana, Albania.
Adela VasiliInstitute of Public Health, Alexander Moisiut Street N.80, 1001, Tirana, Albania.
Rovena DajaInstitute of Public Health, Alexander Moisiut Street N.80, 1001, Tirana, Albania.
Miljana NikaTirana University Hospital "Mother Theresa", Dibra Street N.372, 1001, Tirana, Albania.
Richard PebodyWorld Health Organization, Regional Office for Europe, Marmorvej 51, 2100, Copenhagen, Denmark.
Kathryn E LafondInfluenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Mark A KatzWorld Health Organization, Regional Office for Europe, Marmorvej 51, 2100, Copenhagen, Denmark.
Silvia BinoInstitute of Public Health, Alexander Moisiut Street N.80, 1001, Tirana, Albania.
Institute of Public Health · ALWorld Health Organization Regional Office for Europe · DKBoston Children's Hospital · USBrigham and Women's Hospital · USCenters for Disease Control and Prevention · USEuropean University of Tirana · ALMother Teresa Hospital · AL

Funding

NEVADA IMMUNIZATION INTEROPERABILITY CAPACITY BUILDING U38IP000873 · IP · HEALTH AND HUMAN SERVICES, NEVADA DEPARTMENT OF · PI MACKIE, CHRISTINE N · 2015 to 2015
$625k
NCIRD CDC HHS U38 IP000873World Health Organization 001
6 · The paper itself

Abstract

Background: Healthcare workers (HCWs) have been disproportionally affected by COVID-19. We investigated factors associated with two- and three-dose COVID-19 vaccine uptake and SARS-CoV-2 seropositivity among 1504 HCWs enrolled (19 February-7 May 2021) in a prospective COVID-19 vaccine effectiveness cohort in Albania through a secondary analysis. Methods: We collected sociodemographic, occupational, health, prior SARS-CoV-2 infection, and COVID-19 vaccination data from all HCWs at enrollment. Vaccination status was assessed weekly through June 2022. A serum sample was collected from all participants at enrollment and tested for anti-spike SARS-CoV-2 antibodies. We analyzed HCWs characteristics and outcomes using multivariable logistic regression. Findings: By 11 June 2022, 1337 (88.9%) HCWs had received two COVID-19 vaccine doses, of whom 255 (19.1%) received a booster. Factors significantly associated with receiving three doses (adjusted odds ratio (aOR), 95% CIs) were being ≥35 years (35-44 years: 1.76 (1.05-2.97); 45-54 years: 3.11 (1.92-5.05); ≥55 years: 3.38 (2.04-5.59)) and vaccinated against influenza (1.78; 1.20-2.64). Booster dose receipt was lower among females (0.58; 0.41-0.81), previously infected (0.67; 0.48-0.93), nurses and midwives (0.31; 0.22-0.45), and support staff (0.19; 0.11-0.32). Overall 1076 (72%) were SARS-CoV-2 seropositive at enrollment. Nurses and midwifes (1.45; 1.05-2.02), support staff (1.57; 1.03-2.41), and HCWs performing aerosol-generating procedures (AGPs) (1.40; 1.01-1.94) had higher odds of being seropositive, while smokers had reduced odds (0.55; 0.40-0.75). Interpretation: In a large cohort of Albanian HCWs, COVID-19 vaccine booster dose uptake was very low, particularly among younger, female, and non-physician HCWs, despite evidence demonstrating the added benefit of boosters in preventing infection and severe disease. Reasons behind these disparities should be explored to develop targeted strategies in order to promote uptake in this critical population. SARS-CoV-2 seroprevalence was higher among non-physicians and HCWs performing APGs. A better understanding of the factors contributing to these differences is needed to inform interventions that could reduce infections in the future. Funding: This study was funded by the Task Force for Global Health (US Centers for Disease Control (CDC) cooperative agreement # NU51IP000873) and the World Health Organization, Regional Office for Europe

Indexed as

COVID-19Health care workersRiskSARS-CoV-2SeropositivityVaccination

Identifiers

PMID37013112
PMCPMC9969343
OpenAlexW4322505319

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.